Attached files

file filename
EX-31.2 - EX-31.2 - Alexza Pharmaceuticals Inc.d97339dex312.htm
EX-32.1 - EX-32.1 - Alexza Pharmaceuticals Inc.d97339dex321.htm
EX-10.2 - EX-10.2 - Alexza Pharmaceuticals Inc.d97339dex102.htm
EX-31.1 - EX-31.1 - Alexza Pharmaceuticals Inc.d97339dex311.htm
EX-10.3 - EX-10.3 - Alexza Pharmaceuticals Inc.d97339dex103.htm
EX-10.1 - EX-10.1 - Alexza Pharmaceuticals Inc.d97339dex101.htm
10-Q - FORM 10-Q - Alexza Pharmaceuticals Inc.d97339d10q.htm
v3.2.0.727
Label Element Value
Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration, Liability us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1 $ (7,599)
Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration, Liability us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1 801
Net Income (Loss) Attributable to Parent us-gaap_NetIncomeLoss (12,450)
Net Income (Loss) Attributable to Parent us-gaap_NetIncomeLoss $ (5,962)